OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC financials
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC
2138005SRWT4998BCE35 | Line item | 2023 | 2022 |
|---|---|---|
| Income statement | ||
| Revenue | £0 | £0 |
| Gross profit | -£4.3M | -£2.9M |
| Administrative expenses | £2.7M | £2.3M |
| Operating profit (EBIT) | -£7.0M | -£5.5M |
| Finance costs | £0 | £0 |
| Profit before tax | -£7.0M | -£5.5M |
| Income tax expense | -£1.1M | -£791.1K |
| Profit for the year | -£5.9M | -£4.7M |
| Total comprehensive income | -£5.9M | -£4.7M |
| Cash flow statement | ||
| Net cash from operating activities | -£6.9M | -£5.4M |
| Net cash from investing activities | £0 | £2.5K |
| Net cash from financing activities | £0 | -£94.7K |
| Repayments of borrowings | £0 | £50.0K |
| Lease liability payments | £0 | £44.7K |
| Balance sheet | ||
| Total assets | £4.5M | £11.8M |
| Non-current assets | £7.3K | £46.1K |
| Property, plant & equipment | £0 | £0 |
| Right-of-use assets | £0 | £0 |
| Current assets | £4.5M | £11.8M |
| Trade & other receivables | £2.2M | £2.6M |
| Cash & equivalents | £2.3M | £9.2M |
| Total equity | £3.9M | £9.8M |
| Non-current liabilities | £0 | £0 |
| Current liabilities | £583.9K | £2.0M |
| Short-term borrowings | £0 | — |
| Current portion of long-term borrowings | £0 | £0 |
| Lease liabilities (current) | £0 | — |
| Trade & other payables | £583.9K | £2.0M |
| Derived metrics | ||
| Return on equity | -152.0% | -48.1% |
| Cash conversion ratio | 1.16× | 1.14× |
| Other reported items | ||
| Basic Earnings Loss Per Share From Continuing Operations | £0.62 | £0.49 |
| Diluted Earnings Loss Per Share From Continuing Operations | £0.62 | £0.49 |
| Finance Income | £3.8K | £0 |
| Income Taxes Paid Refund Classified As Operating Activities | -£170.0K | £0 |
| Increase Decrease In Cash and Cash Equivalents | -£6.9M | -£5.5M |
| Increase Decrease Through Transactions With Owners | £63.9K | £291.6K |
| Intangible Assets Other Than Goodwill | £7.3K | £46.1K |
| Interest Received Classified As Operating Activities | £3.8K | £0 |
| Issued Capital | £9.6M | £9.6M |
| Liabilities | £583.9K | £2.0M |
| Net Assets Liabilities | £3.9M | £9.8M |
| Other Comprehensive Income | £0 | £0 |
| Other Expense By Function | £63.9K | £291.6K |
| Other Reserves | £643.5K | £643.5K |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | £0 | £2.5K |
| Research and Development Expense | £4.3M | £2.9M |
| Reserve of Sharebased Payments | £1.5M | £1.4M |
| Retained Earnings | -£19.7M | -£13.8M |
| Share Premium | £11.9M | £11.9M |
Every line item above is a fact tagged in OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (GBP), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.